.svg){kind=small}
Risk mitigation is increasingly important in early medicines development not only to allow early attrition but also to improve the chances of early drug development.Join us at the 23rd AGAH Annual Meeting taking place 13-14 March 2014 in Munich, Germany. Discussions will take into account the impact of nonclinical findings, biopharmaceutics, personalised medicine approaches, updates on safety/tolerability from a clinical pharmacology perspective, as well as early investigation of lack of efficacy.View program and register online
-min.jpg)
.jpg)
Latest news
Richmond Pharmacology Announces Promotions of Dr Matej Goricar and Dr Amir Majid
December 1, 2024
Richmond is pleased to announce the promotions of Dr Matej Goricar and Dr Amir Majid to senior roles within the Medical Directorate as Associate Medical Directors.
Read moreRichmond trains taxi drivers to deliver lifesaving CPR
December 3, 2024
Richmond has just trained a first group of taxi drivers to deliver cardiopulmonary resuscitation (CPR) aimed at saving the lives of their passengers.
Read moreEvents
Pulse Virtual: Respiratory, CVD, Diabetes and Nutrition
Wednesday 18th September
Richmond will be presenting at the upcoming Pulse Virtual Event aimed at GPs
View event
